Measurement of patients' bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay: a comparison to a standard activated clotting time

Anesthesia and Analgesia
Roger C CarrollEli Cohen

Abstract

Standard activated clotting time (ACT) tests have a poor correlation to bivalirudin levels, leading to uncertainty regarding adequate anticoagulation in percutaneous coronary intervention patients. We tested a Thrombelastograph (TEG) ecarin clotting time (ECT) assay for sensitivity to bivalirudin using blood from 80 patients undergoing interventional cardiology procedures with bivalirudin anticoagulation. This was compared to a standard Hemochron ACT assay using diatomaceous earth. With the TEG assay, the direct thrombin activator, ecarin, was used to initiate coagulation and measured as the reaction time. Plasma samples were evaluated for bivalirudin by a chromogenic assay at an independent hematological laboratory. Linear regression of the standard ACT versus bivalirudin level gave an r = 0.306 whereas the TEG ECT gave a much higher r2 = 0.746 (both P < 0.0001). The TEG ECT should prove more useful than the standard ACT for monitoring bivalirudin anticoagulation across the clinically therapeutic range.

References

Oct 24, 2002·Journal of Clinical Anesthesia·Evan G Pivalizza
Nov 7, 2002·Seminars in Thrombosis and Hemostasis·Gerd HafnerMatthias Nauck
Jan 23, 2003·Anesthesia and Analgesia·Andreas KosterBruce D Spiess
Apr 26, 2003·The American Journal of Cardiology·Leslie ChoDavid J Moliterno
Feb 19, 2004·The American Journal of Cardiology·Joseph E MobleyRoger C Carroll
May 4, 2004·The Journal of Laboratory and Clinical Medicine·Robert M CraftRoger C Carroll
Nov 25, 2004·Anesthesia and Analgesia·Nobuyuki KatoriKenichi A Tanaka

❮ Previous
Next ❯

Citations

May 8, 2013·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Erin L NagleRobert K Pretzlaff
Jan 29, 2013·Anesthesiology Clinics·Oliver M Theusinger, Jerrold H Levy
Sep 4, 2008·Anesthesiology Clinics·Daniel Bainbridge, Wojciech Dobkowski
Feb 15, 2018·Journal of Clinical Medicine·Stephanie A JoppaFadi Shamoun
Apr 19, 2008·Anesthesia and Analgesia·Michael T Ganter, Christoph K Hofer
Feb 21, 2018·Anesthesia and Analgesia·Katherine L ZaleskiViviane G Nasr
Dec 6, 2017·Anesthesiology·Andreas KosterJerrold H Levy
Oct 28, 2016·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Jessika IwanskiZain Khalpey
Jan 7, 2017·Hospital Pharmacy·Maria CardinaleDavid P Reardon
Sep 26, 2020·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Lindsay M RyersonMary E Bauman
Jan 11, 2021·Paediatric Anaesthesia·Philip WolstencroftBrian J Anderson
May 23, 2020·JACC. Clinical Electrophysiology·Jonathan P Piccini, Jeffrey B Washam
Apr 12, 2020·JACC. Clinical Electrophysiology·Aleksandr VoskoboinikEdward P Gerstenfeld
May 1, 2021·Current Opinion in Critical Care·Jakob JosiassenChristian Hassager
Aug 23, 2012·Best Practice & Research. Clinical Anaesthesiology·Klaus GörlingerDaniel Dirkmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.